Notice of Results and Capital Markets Day

Oxford Nanopore Technologies plc
25 August 2023
 

 

25 August 2023

Oxford Nanopore Technologies plc 

Notice of Results and Capital Markets Day

Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore" or the "Group"), the company behind a new generation of molecular sensing technology based on nanopores, will announce its interim results for the six months ended 30 June 2023, on Wednesday 6 September 2023.

Management will host a virtual presentation on the same day, at 12:00pm BST/ 7:00am EDT, followed by a Q&A session, accessible via conference call or webcast. To access the webcast please register via this link. The webcast will also be available on Oxford Nanopore's website at  https://nanoporetech.com/about-us/investors/reports. The same link will provide access to a replay of the webcast shortly after the event concludes.

Alternatively, please contact OxfordNanoporeTechnologies@teneo.com for details of the conference call.

Details of the Capital Markets Day - 19th October 2023

Oxford Nanopore will be hosting a Capital Markets Day for institutional investors and sell-side analysts on Thursday, 19 October 2023 from 12:00pm. The event will be held at The Science Museum, Exhibition Rd, South Kensington, London SW7 2DD.

The event will include presentations and Q&A sessions from Oxford Nanopore's Executive Leadership Team, product demonstrations and a customer panel.

Places are limited so if you would like to attend in-person please contact ir@nanoporetech.com. The event will also be webcast live.

-Ends-

Enquiries:

 

Investors

ir@nanoporetech.com  

 

Media

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com

 

About Oxford Nanopore Technologies

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for real-time, high-performance, accessible and scalable analysis of DNA and RNA. The technology is used in more than 120 countries to understand the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses and whole environments.

For more information please visit: www.nanoporetech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100